OMIC Insider Trading Activity and SEC Form 4 Filings
OMIC insider trading summary
No open-market insider purchases or sales of Singular Genomics Systems, Inc. (OMIC) have been reported on SEC Form 4 in the past 12 months.
Latest OMIC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 14, 2025 | Andrew Spaventa | Chief Executive Officer | Sell | $16K (800 @ $19.89) |
| Dec 16, 2024 | Andrew Spaventa | Chief Executive Officer | Sell | $4K (180 @ $20.16) |
| Nov 12, 2024 | Andrew Spaventa | Chief Executive Officer | Sell | $16K (695 @ $22.55) |
| Sep 18, 2024 | Tang Capital Management LLC | 10% Owner | Buy | $551K (32,000 @ $17.21) |
| Sep 18, 2024 | Kevin Tang | Insider | Buy | $551K (32,000 @ $17.21) |
| Sep 18, 2024 | Tang Capital Partners LP | 10% Owner | Buy | $551K (32,000 @ $17.21) |
| Sep 17, 2024 | Kevin Tang | Insider | Buy | $613K (40,000 @ $15.33) |
| Sep 17, 2024 | Tang Capital Partners LP | 10% Owner | Buy | $613K (40,000 @ $15.33) |
| Sep 17, 2024 | Tang Capital Management LLC | 10% Owner | Buy | $613K (40,000 @ $15.33) |
| Sep 16, 2024 | Tang Capital Partners LP | 10% Owner | Buy | $642K (50,416 @ $12.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.